- Home
- BNTX vs ONC Comparison
BNTX vs ONC Comparison
Compare BNTX & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- ONC
- Stock Information
- Founded
- BNTX 2008
- ONC 2010
- Country
- BNTX Germany
- ONC Cayman Islands
- Employees
- BNTX N/A
- ONC N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- ONC Biotechnology: Pharmaceutical Preparations
- Sector
- BNTX Health Care
- ONC Health Care
- Exchange
- BNTX Nasdaq
- ONC Nasdaq
- Market Cap
- BNTX 23.9B
- ONC 19.3B
- IPO Year
- BNTX 2019
- ONC N/A
- Fundamental
- Price
- BNTX $93.32
- ONC $274.78
- Analyst Decision
- BNTX Strong Buy
- ONC Buy
- Analyst Count
- BNTX 17
- ONC 2
- Target Price
- BNTX $145.88
- ONC $330.50
- AVG Volume (30 Days)
- BNTX 954.9K
- ONC 437.3K
- Earning Date
- BNTX 05-05-2025
- ONC 05-07-2025
- Dividend Yield
- BNTX N/A
- ONC N/A
- EPS Growth
- BNTX N/A
- ONC N/A
- EPS
- BNTX N/A
- ONC N/A
- Revenue
- BNTX $2,848,224,455.00
- ONC $3,810,241,000.00
- Revenue This Year
- BNTX N/A
- ONC $856.26
- Revenue Next Year
- BNTX $8.57
- ONC $19.78
- P/E Ratio
- BNTX N/A
- ONC N/A
- Revenue Growth
- BNTX N/A
- ONC 54.97
- 52 Week Low
- BNTX $76.53
- ONC $126.97
- 52 Week High
- BNTX $131.49
- ONC $287.88
- Technical
- Relative Strength Index (RSI)
- BNTX 38.18
- ONC N/A
- Support Level
- BNTX $85.55
- ONC N/A
- Resistance Level
- BNTX $101.69
- ONC N/A
- Average True Range (ATR)
- BNTX 3.71
- ONC 0.00
- MACD
- BNTX -0.18
- ONC 0.00
- Stochastic Oscillator
- BNTX 44.99
- ONC 0.00
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.